Peter Winocour
Impact in
- Clinical Biochemistry top 0.5%
- Paraoxonase enzyme and polymorphisms
- Advanced Glycation End Products research
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 29
- Diabetes Management and Research 26
- Diabetes, Cardiovascular Risks, and Lipoproteins 25
- Surgery 25
- Lipoproteins and Cardiovascular Health 14
- Co-authors
- Ken Farrington (10 shared papers)Dhruv K. Singh (10 shared papers)Deepak Bhatnagar (15 shared papers)Paul N. Durrington (11 shared papers)Sharon Arrol (9 shared papers)M F Laker (11 shared papers)Monica Ishola (6 shared papers)Michael I. Mackness (3 shared papers)
- Journals
- Diabetic Medicine (23 papers)Diabetes Research and Clinical Practice (8 papers)Atherosclerosis (6 papers)Clinical Medicine (5 papers)Postgraduate Medical Journal (4 papers)
- Partner nations
- United KingdomIranAustralia
In The Last Decade
Peter Winocour
114 papers receiving 3.1k citations
Peter Winocour's Hit Papers
Peers
Comparison fields: 5 of 122
- Clinical Biochemistry 563
- Nephrology 467
- Endocrinology, Diabetes and Metabolism 1.1k
- Biochemistry 146
- Biochemistry 106
Countries citing papers authored by Peter Winocour
This map shows the geographic impact of Peter Winocour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Winocour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Winocour more than expected).
Fields of papers citing papers by Peter Winocour
This network shows the impact of papers produced by Peter Winocour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Winocour. The network helps show where Peter Winocour may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Winocour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus Hit paper breakdown → | 1991 | 434 |
| 2 | 2010 | 311 | |
| 3 | 2008 | 171 | |
| 4 | 1992 | 136 | |
| 5 | 2003 | 122 | |
| 6 | 1991 | 103 | |
| 7 | 1987 | 102 | |
| 8 | 1993 | 99 | |
| 9 | 2009 | 97 | |
| 10 | 1997 | 82 | |
| 11 | 1993 | 76 | |
| 12 | 2002 | 75 | |
| 13 | 2017 | 74 | |
| 14 | 1990 | 59 | |
| 15 | 2022 | 49 | |
| 16 | 1991 | 47 | |
| 17 | 1994 | 47 | |
| 18 | 1992 | 44 | |
| 19 | 1994 | 43 | |
| 20 | 2010 | 42 |
About Peter Winocour
Peter Winocour is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 122 papers that have together received 3.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (29 papers), Diabetes Management and Research (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers), Chronic Kidney Disease and Diabetes (16 papers), Lipoproteins and Cardiovascular Health (14 papers), Blood Pressure and Hypertension Studies (8 papers), Metabolism, Diabetes, and Cancer (8 papers) and Diabetes and associated disorders (7 papers). The work is most often cited by research in Clinical Biochemistry (563 citations), Nephrology (467 citations), Endocrinology, Diabetes and Metabolism (1.1k citations), Biochemistry (146 citations) and Biochemistry (106 citations). Peter Winocour has collaborated with scholars based in United Kingdom, Iran and Australia. Frequent co-authors include Ken Farrington, Dhruv K. Singh, Deepak Bhatnagar, Paul N. Durrington, Sharon Arrol, M F Laker, Monica Ishola, Michael I. Mackness, David C. Anderson and D. W. S. Harty. Their work appears in journals such as Diabetic Medicine, Diabetes Research and Clinical Practice, Atherosclerosis, Clinical Medicine and Postgraduate Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.